Risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
At the request of the European Commission’s Directorate-General for Health and Consumers, a rapid risk assessment has been prepared concerning the outbreak of E Coli in Germany.
Outbreak of Shiga toxin-producing E. coli (STEC) in Germany, May 2011
Shiga toxin-producing E. coli (STEC) is a group of pathogenic Escherichia coli strains capable of producing Shiga toxins, with the potential to cause severe enteric and systemic disease in humans.
Revised risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
An update of the initial rapid risk assessment on the outbreak of E. Coli in Germany, prepared at the request of the European Commission, first published on 27 May 2011.
Rapid risk assessment update: Outbreak of Shiga toxin-producing E. coli (STEC) O104:H4 2011 in the EU, 8 July 2011
This document is an update of the EFSA/ECDC joint rapid risk assessment of 29 June and aims to add new information to this and earlier initial rapid risk assessments (27 May and 14 June 2011).
ECDC rapid risk assessment: Influenza of possible swine origin in human in Spain
Influenza of swine origin detected retrospectively in a human with illness in November 2008. Swine influenza (SI) is an acute viral infection of the respiratory tract in pigs. Subclinical infections are also common. The mortality is low and recovery usually occurs within 7-10 days.
Risk assessment: New Orthobunyavirus isolated from infected cattle and small livestock ─ potential implications for human health
Based on current evidence, it is not possible to confirm or exclude a causal relationship between detection of the new orthobunyavirus and the observed clinical symptoms in cattle and small livestock.
Joint risk assessment: New Orthobunyavirus isolated from infected cattle and small livestock ─ potential implications for human health
This updated rapid risk assessment was prepared jointly with the Robert Koch Institute (RKI), Germany, and the National Institute of Public Health and the Environment (RIVM), Netherlands.
Joint rapid risk assessment: Anthrax cases among injecting drug users, Germany, 22 June 2012
Following reports of two cases of anthrax among injecting drug users in Germany, ECDC and EMCDDA jointly prepared a rapid risk assessment.
Rapid risk assessment: Anthrax cases among injecting drug users - Germany, June-July 2012 - Update, 6 July 2012
This is an update to the joint rapid risk assessment published on 22 June 2012 by ECDC and EMCDDA on anthrax cases among injecting drug users in Germany. This is in response to a third case in Berlin. It contains information updated up to the 6 July 2012.